Practical considerations when treating chronic hepatitis E in solid organ transplant recipients.
Hepatitis E virus
Liver transplant
Ribavirin
Transplant
Journal
International journal of clinical pharmacy
ISSN: 2210-7711
Titre abrégé: Int J Clin Pharm
Pays: Netherlands
ID NLM: 101554912
Informations de publication
Date de publication:
Jun 2021
Jun 2021
Historique:
received:
23
06
2020
accepted:
03
11
2020
revised:
31
10
2020
pubmed:
11
11
2020
medline:
16
10
2021
entrez:
10
11
2020
Statut:
ppublish
Résumé
Hepatitis E virus (HEV) can lead to chronic infections in immunosuppressed patients. The use of ribavirin to treat chronic HEV has been well-established in case reports and guidelines. However, practical approaches to the use of this antiviral treatment in a post-transplant patient, including drug interactions, dosing adjustments, and monitoring parameters, are lacking. Thus, we present our real-world approach to the use of ribavirin to treat chronic HEV in a solid organ transplant recipient.
Identifiants
pubmed: 33169803
doi: 10.1007/s11096-020-01195-x
pii: 10.1007/s11096-020-01195-x
doi:
Substances chimiques
Antiviral Agents
0
Ribavirin
49717AWG6K
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
753-755Références
Hepatitis E. World Health Organization. 2020. https://www.who.int/news-room/fact-sheets/detail/hepatitis-e . Accessed 1 Oct 2020.
Hepatitis E. Centers for Disease Control and Prevention. 2020. https://www.cdc.gov/hepatitis/hev/index.htm . Accessed 1 Oct 2020.
European Association for the Study of the Liver. EASL clinical practice guidelines on hepatitis E virus infection. J Hepatol. 2018;68(6):1256–71.
doi: 10.1016/j.jhep.2018.03.005
Kamar N, Izopet J, Tripon S, Bismuth M, Hillaire S, Dumortier J, et al. Ribavirin for chronic hepatitis E virus infection in transplant recipients. N Engl J Med. 2014;370(12):1111–20.
doi: 10.1056/NEJMoa1215246
Colson P, Decoster C. Recent data on hepatitis E. Curr Opin Infect Dis. 2019;32(5):475–81.
doi: 10.1097/QCO.0000000000000590